BioPharmSignal logoBioPharmSignal

Biotech News

Lineage Achieves First Milestone Under Worldwide Collaboration Agreement with Genentech

Lineage Cell Therapeutics (LCTX)Lineage Cell Therapeutics2026-06-25 13:46 ESTPartnership

LINEAGE ACHIEVES FIRST MILESTONE UNDER WORLDWIDE COLLABORATION AGREEMENT WITH GENENTECH November 24, 2025 Lineage Cell Therapeutics, Inc. today announced it had achieved the first milestone available under its worldwide collaboration with Roche and Genentech , a member of the Roche Group, for

Open original release

Related news

LCTXLineage Cell Therapeutics2026-07-06 12:00 EST

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Cell Therapeutics Issues Letter to Stockholders

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Announces Formation of Scientific Advisory Board

LCTXLineage Cell Therapeutics2026-06-25 13:46 EST

Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026

View all latest news

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

Recent company news

LCTXZimmer Biomet2026-07-14 12:13 EST

Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

LCTXZimmer Biomet2026-07-13 12:14 EST

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results

LCTXBMYBristol-Myers Squibb Company2026-07-13 10:59 EST

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

LCTXGSK plc2026-07-13 07:00 EST

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

LCTXMerck2026-07-10 19:01 EST

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)

Stock data

Close
1.21 USD
Market cap
319.1M USD
Exchange
NASDAQ
Sector
Biotechnology
Location
United States